Inventor · disambiguated record
Steven G. Reed
Also filed as: REED STEVEN · REED STEVEN G · REED STEVEN GREGORY
147 granted patents·50 pending applications·2,519 citations·filing 1992–2025
99Inventor score
Files withCORIXA CORP87INFECTIOUS DISEASE RES INST27HDT BIO CORP21ACCESS TO ADVANCED HEALTH INST12REED STEVEN G11
Top patents by PatentIndex Score
197 records- 0198US11534497B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2022·Granted Dec 27, 2022·16 cites·30 claims
- 0298US11458209B2Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigenHDT BIO CORP·Filed 2021·Granted Oct 4, 2022·16 cites·28 claims
- 0398US11433142B2Compositions and methods for delivery of RNA-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigenHDT BIO CORP·Filed 2022·Granted Sep 6, 2022·15 cites·30 claims
- 0498US11376335B2RNA-lipid nanoparticle complexes of viral RNA polymerase region and SARS-CoV-2 spike protein regionHDT BIO CORP·Filed 2021·Granted Jul 5, 2022·17 cites·29 claims
- 0598US11318213B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2021·Granted May 3, 2022·20 cites·28 claims
- 0697US11752218B2Nucleic acid-small diameter and liquid core nanoparticle complexed compositionsHDT BIO CORP·Filed 2022·Granted Sep 12, 2023·3 cites·33 claims
- 0797US11654200B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2022·Granted May 23, 2023·3 cites·43 claims
- 0897US11648321B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2022·Granted May 16, 2023·2 cites·30 claims
- 0997US11648322B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2022·Granted May 16, 2023·3 cites·33 claims
- 1097US8722064B2Synthetic glucopyranosyl lipid adjuvantsREED STEVEN G·Filed 2010·Granted May 13, 2014·46 cites·20 claims
- 1197US8273361B2Vaccine composition containing synthetic adjuvantREED STEVEN G·Filed 2007·Granted Sep 25, 2012·40 cites·20 claims
- 1297US7335369B2Fusion proteins of mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 2006·Granted Feb 26, 2008·26 cites·15 claims
- 1397US7261897B2Fusion proteins of mycobacterium tuberculosisCORIXA CORP·Filed 2006·Granted Aug 28, 2007·56 cites·13 claims
- 1497US6949246B2Compounds and methods for diagnosis of tuberculosisCORIXA CORP·Filed 2002·Granted Sep 27, 2005·66 cites·7 claims
- 1596US11896677B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2023·Granted Feb 13, 2024·1 cites·30 claims
- 1696US9480740B2Synthetic glucopyranosyl lipid adjuvantsINFECTIOUS DISEASE RES INST·Filed 2014·Granted Nov 1, 2016·28 cites·10 claims
- 1796US8840908B2Vaccine composition containing synthetic adjuvantREED STEVEN G·Filed 2012·Granted Sep 23, 2014·25 cites·13 claims
- 1896US8609114B2Methods of using a vaccine composition containing synthetic adjuvantREED STEVEN G·Filed 2012·Granted Dec 17, 2013·28 cites·38 claims
- 1996US8343512B2Treatment of allergic conditions using a composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2011·Granted Jan 1, 2013·30 cites·20 claims
- 2096US7122196B2Compounds and methods for diagnosis of tuberculosisCORIXA CORP·Filed 2005·Granted Oct 17, 2006·38 cites·5 claims
- 2195US10632191B2Synthetic glucopyranosyl lipid adjuvantsINFECTIOUS DISEASE RES INST·Filed 2017·Granted Apr 28, 2020·6 cites·15 claims
- 2295US9950063B2Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2014·Granted Apr 24, 2018·16 cites·18 claims
- 2395US9907845B2Methods of using a vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2013·Granted Mar 6, 2018·17 cites·22 claims
- 2495US7691993B2Fusion proteins of Mycobacterium tuberculosisCORIXA CORP·Filed 2007·Granted Apr 6, 2010·28 cites·16 claims
- 2595US6962710B2Compounds and methods for immunotherapy and diagnosis of tuberculosisCORIXA CORP·Filed 2002·Granted Nov 8, 2005·34 cites·5 claims
- 2694US11679163B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2022·Granted Jun 20, 2023·2 cites·31 claims
- 2794US7083796B2Fusion proteins of mycobacterium tuberculosisCORIXA CORP·Filed 2001·Granted Aug 1, 2006·36 cites·28 claims
- 2893US12433957B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2024·Granted Oct 7, 2025·0 cites·22 claims
- 2993US9987355B2Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2013·Granted Jun 5, 2018·13 cites·14 claims
- 3093US7678375B2Fusion proteins of Mycobacterium tuberculosisCORIXA CORP·Filed 2006·Granted Mar 16, 2010·20 cites·18 claims
- 3193US7311922B1Fusion proteins of mycobacterium tuberculosisCORIXA CORP·Filed 2000·Granted Dec 25, 2007·44 cites·35 claims
- 3293US7026465B2Fusion proteins of Mycobacterium tuberculosisCORIXA CORP·Filed 2003·Granted Apr 11, 2006·33 cites·26 claims
- 3393US6977069B2Fusion proteins of Mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 2003·Granted Dec 20, 2005·27 cites·9 claims
- 3492US8410258B2Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasisGOTO YASUYUKI·Filed 2009·Granted Apr 2, 2013·13 cites·11 claims
- 3591US12133894B2Compositions and methods for delivery of RNAHDT BIO CORP·Filed 2023·Granted Nov 5, 2024·0 cites·22 claims
- 3691US8486414B2Immunogenic compositions comprising Mycobacterium tuberculosis polypeptides and fusions thereofREED STEVEN G·Filed 2008·Granted Jul 16, 2013·19 cites·18 claims
- 3791US8231881B2Fusion proteins and their use in the diagnosis and treatment of leishmaniasisBHATIA AJAY·Filed 2009·Granted Jul 31, 2012·17 cites·10 claims
- 3891US8110201B2Fusion proteins of mycobacterium tuberculosisSKEIKY YASIR·Filed 2010·Granted Feb 7, 2012·7 cites·11 claims
- 3991US7186412B1Fusion proteins of Mycobacterium tuberculosisCORIXA CORP·Filed 2000·Granted Mar 6, 2007·38 cites·27 claims
- 4090US6627198B2Fusion proteins of Mycobacterium tuberculosis antigens and their usesCORIXA CORP·Filed 1999·Granted Sep 30, 2003·64 cites·9 claims
- 4190US6306402B1Compounds and methods for the diagnosis and treatment of EHRLICHIA infectionCORIXA CORP·Filed 1998·Granted Oct 23, 2001·59 cites·14 claims
- 4290US6207169B1Compounds and methods for the diagnosis and treatment of Ehrlichia infectionCORIXA CORP·Filed 1997·Granted Mar 27, 2001·66 cites·3 claims
- 4390US6034218ACompounds and methods for immunotherapy and immunodiagnosis of prostate cancerCORIXA CORP·Filed 1997·Granted Mar 7, 2000·96 cites·3 claims
- 4489US9655958B2Method for preventing or treating M tuberculosis infectionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted May 23, 2017·7 cites·1 claims
- 4589US8067016B2Fusion proteins of Mycobacterium tuberculosisSKEIKY YASIR·Filed 2009·Granted Nov 29, 2011·10 cites·9 claims
- 4689US7238358B2Compounds and methods for immunotherapy and diagnosis of tuberculosisCORIXA CORP·Filed 2005·Granted Jul 3, 2007·8 cites·10 claims
- 4789US6828431B1Compositions and methods for the therapy and diagnosis of breast cancerCORIXA CORP·Filed 2000·Granted Dec 7, 2004·27 cites·4 claims
- 4889US6231869B1Compounds and methods for the diagnosis and treatment of ehrlichia infectionCORIXA CORP·Filed 1997·Granted May 15, 2001·69 cites·3 claims
- 4988US10792359B2Methods of using a vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2018·Granted Oct 6, 2020·1 cites·28 claims
- 5088US10765736B2Vaccine composition containing synthetic adjuvantINFECTIOUS DISEASE RES INST·Filed 2017·Granted Sep 8, 2020·1 cites·27 claims
Showing the top 50 of 197 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven G. Reed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →